# Sadra Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sadra-medical

- Industry: Medical Devices & Equipment
- Headquarters: Los Gatos, US
- Website: www.sadramedical.com
- Total disclosed funding: $62M
- Latest round: Series D (Sep 21, 2010)
- Investors on record: 9

## About

Sadra Medical is focused on developing innovative medical solutions, particularly in the field of cardiovascular care. Their products aim to enhance patient outcomes through advanced therapeutic devices.Sadra Medical, founded in 2003 in Los Gatos, US, specializes in developing medical devices aimed at addressing cardiovascular health issues. The company, acquired by Boston Scientific on January 4, 2011, was targeted for its innovative offerings, with the deal valued at USD 193 mn for the remaining equity. Boston Scientific Ventures was a significant investor in this acquisition. The acquisition included provisions for an additional USD 193 mn contingent on performance targets.Sadra Medical specializes in advanced cardiovascular therapeutic devices that target critical health conditions. Their flagship product is the WATCHMAN™ Implant, designed for stroke risk reduction in atrial fibrillation patients. The company also offers innovative solutions for chronic pain and related disorders, contributing to improved patient care across healthcare settings in North America, Europe, and Asia.Sadra Medical's revenue model is based on supplying medical devices to healthcare providers and institutions. These transactions often involve B2B sales with strategic partnerships that enhance distribution to hospitals and clinics. Their core offerings, including the WATCHMAN™ Implant, generate substantial revenue through bulk orders and long-term agreements with healthcare providers.Sadra Medical plans to leverage its recent acquisition by Boston Scientific to enhance its product offerings and expand into new markets. The company is focusing on launching new cardiovascular devices, with anticipated release dates to be announced. The funding received from the acquisition will support these product developments and facilitate entry into additional markets in Europe and Asia, aligning with Boston Scientific's broader growth strategy.

## Funding rounds

- Series D, Sep 21, 2010, $4M — ONSET Ventures, SV Life Sciences
- Seed, Jun 1, 2009 — SV Health Investors
- Series C, May 4, 2009, $30M — Accuitive Medical Ventures, SV Health Investors, ONSET Ventures, Oakwood Medical Investors, Boston Scientific Ventures, FirstMark Capital, Finistere Ventures
- Series B, Sep 30, 2006, $19M — SV Health Investors, ONSET Ventures, Oakwood Medical Investors, Boston Scientific Ventures, Pequot Ventures
- Series A, Jun 16, 2004, $9M — SV Health Investors, ONSET Ventures, Pequot Ventures

## Investors

- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A, Series B, Series C, Seed
- ONSET Ventures (https://capitalatlas.ai/funds/onset-ventures) — Series A, Series B, Series C, Series D
- Pequot Ventures (https://capitalatlas.ai/funds/pequot-ventures) — Series A, Series B
- Oakwood Medical Investors (https://capitalatlas.ai/funds/oakwood-medical-investors) — Series B, Series C
- Boston Scientific Ventures (https://capitalatlas.ai/funds/boston-scientific-ventures) — Series B, Series C
- Accuitive Medical Ventures (https://capitalatlas.ai/funds/accuitive-medical-ventures) — Series C
- FirstMark Capital (https://capitalatlas.ai/funds/firstmark-capital) — Series C
- Finistere Ventures (https://capitalatlas.ai/funds/finistere-ventures) — Series C
- SV Life Sciences — Series D